Cancer driver genes, i.e., oncogenes and tumor suppressor genes, are involved in the acquisition of important functions in tumors, providing a selective growth advantage, allowing uncontrolled proliferation and avoiding apoptosis. It is therefore important to identify these driver genes, both for the fundamental understanding of cancer and to help finding new therapeutic targets or biomarkers. Although the most frequently mutated driver genes have been identified, it is believed that many more remain to be discovered, particularly for driver genes specific to some cancer types. In this paper, we propose a new computational method called LOTUS to predict new driver genes. LOTUS is a machine-learning based approach which allows to integrate various types of data in a versatile manner, including information about gene mutations and protein-protein interactions. In addition, LOTUS can predict cancer driver genes in a pan-cancer setting as well as for specific cancer types, using a multitask learning strategy to share information across cancer types. We empirically show that LOTUS outperforms five other state-of-the-art driver gene prediction methods, both in terms of intrinsic consistency and prediction accuracy, and provide predictions of new cancer genes across many cancer types.
Nature. 2013 Jul 11;499(7457):214-218
[PMID:
23770567]
Gene. 2015 Sep 15;569(2):153-61
[PMID:
26074087]
Nucleic Acids Res. 2016 Jan 4;44(D1):D975-9
[PMID:
26635391]
Int J Mol Med. 2018 Apr;41(4):2185-2192
[PMID:
29393380]
J Transl Med. 2018 Dec 27;16(1):372
[PMID:
30587197]
Genome Med. 2017 Aug 25;9(1):79
[PMID:
28841835]
Nat Rev Cancer. 2004 Mar;4(3):177-83
[PMID:
14993899]
Nature. 2012 Mar 28;483(7391):603-7
[PMID:
22460905]
Cancer Metastasis Rev. 2019 Jun;38(1-2):223-236
[PMID:
30618016]
Oncotarget. 2016 Apr 26;7(17):23312-21
[PMID:
27004405]
Carcinogenesis. 2018 Feb 9;39(2):293-304
[PMID:
29236960]
Nat Genet. 2015 Feb;47(2):106-14
[PMID:
25501392]
Cell. 2011 Mar 4;144(5):646-74
[PMID:
21376230]
Nature. 1984 Dec 6-12;312(5994):513-6
[PMID:
6095109]
J Pathol. 2017 Nov;243(3):342-353
[PMID:
28771744]
Genome Med. 2014 Jun 10;6(6):44
[PMID:
25690659]
Cell. 2018 Apr 5;173(2):371-385.e18
[PMID:
29625053]
Nature. 2011 Jul 27;476(7360):298-303
[PMID:
21796119]
Mol Syst Biol. 2013;9:637
[PMID:
23340843]
BMC Bioinformatics. 2011 Oct 06;12:389
[PMID:
21977986]
Oncogene. 2018 Feb 15;37(7):912-923
[PMID:
29059173]
Database (Oxford). 2011 Sep 19;2011:bar026
[PMID:
21930502]
J Korean Med Sci. 2015 Jul;30(7):937-42
[PMID:
26130958]
Nucleic Acids Res. 2012 Nov;40(21):e169
[PMID:
22904074]
Science. 2013 Mar 29;339(6127):1546-58
[PMID:
23539594]
Oncogene. 2008 Jun 19;27(27):3865-9
[PMID:
18223676]
Cell. 2013 Nov 7;155(4):948-62
[PMID:
24183448]
Nucleic Acids Res. 2009 Jan;37(Database issue):D767-72
[PMID:
18988627]
Nature. 2014 Jan 23;505(7484):495-501
[PMID:
24390350]
Nature. 2008 Oct 23;455(7216):1069-75
[PMID:
18948947]
Oncotarget. 2016 Dec 6;7(49):80612-80632
[PMID:
27811361]
Int J Cancer. 2015 May 15;136(10):2316-27
[PMID:
25335771]
Pharmacol Ther. 2017 Nov;179:171-187
[PMID:
28564583]
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):14330-14335
[PMID:
27911828]
Oncogene. 2018 Aug;37(33):4505-4517
[PMID:
29743591]
Blood. 2014 Apr 17;123(16):2451-9
[PMID:
24608975]
Oncotarget. 2015 Dec 22;6(41):43452-71
[PMID:
26496030]
J Biol Chem. 2002 Apr 12;277(15):13302-11
[PMID:
11809771]
Clin Cancer Res. 2018 Aug 1;24(15):3668-3680
[PMID:
29716922]
N Engl J Med. 2007 Jul 5;357(1):39-51
[PMID:
17611206]
Science. 2004 Jun 4;304(5676):1497-500
[PMID:
15118125]
Gynecol Oncol. 2003 Aug;90(2):378-81
[PMID:
12893203]
J Biol Chem. 2014 Nov 28;289(48):33343-54
[PMID:
25320087]
Nucleic Acids Res. 2017 Jan 4;45(D1):D777-D783
[PMID:
27899578]
Br J Haematol. 2016 Jul;174(2):292-301
[PMID:
27022003]
Nat Genet. 2013 Oct;45(10):1113-20
[PMID:
24071849]
Oncotarget. 2016 Sep 27;7(39):62925-62938
[PMID:
26910837]
Biomed Pharmacother. 2016 Apr;79:315-20
[PMID:
27044843]
Hum Pathol. 2014 Oct;45(10):1995-2005
[PMID:
25128227]
Cell. 2000 Jan 7;100(1):57-70
[PMID:
10647931]
Cancer Cell. 2017 Apr 10;31(4):549-562.e11
[PMID:
28399410]
Apoptosis. 2015 Oct;20(10):1321-37
[PMID:
26201458]
Nature. 2013 Aug 22;500(7463):415-21
[PMID:
23945592]
Nat Rev Genet. 2017 Sep;18(9):551-562
[PMID:
28607512]
Genome Biol. 2016 Jun 23;17(1):129
[PMID:
27333808]
Oncol Lett. 2018 Nov;16(5):6721-6728
[PMID:
30405814]
Front Genet. 2015 Apr 23;6:157
[PMID:
25954303]
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7077-7082
[PMID:
28630300]
Nature. 2012 Sep 27;489(7417):519-25
[PMID:
22960745]
Genome Biol. 2012 Dec 22;13(12):R124
[PMID:
23383675]
Nucleic Acids Res. 2017 Dec 15;45(22):13043-13055
[PMID:
29069470]
Immunogenetics. 2018 Feb;70(2):73-86
[PMID:
28642997]
Genome Res. 2012 Aug;22(8):1589-98
[PMID:
22759861]
Onco Targets Ther. 2016 Jan 08;9:217-22
[PMID:
26811690]
Science. 1990 Dec 14;250(4987):1576-80
[PMID:
2274789]
Gene. 2018 Oct 30;675:44-53
[PMID:
29960071]
PLoS Comput Biol. 2015 Jan 08;11(1):e1004027
[PMID:
25569148]
Cancer Med. 2018 Jan;7(1):157-166
[PMID:
29168346]
